NC
ELGX

Nicholas Company’s Endologix Inc ELGX Stock Holding History

Nicholas Company’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-17,670
Closed -$2.27M – 258
2014
Q1 		$2.27M Buy
17,670
+100
+0.6% +$15.5K 0.05% 215
2013
Q4 		$3.06M Hold
17,570
– – 0.07% 205
2013
Q3 		$2.83M Sell
17,570
-25
-0.1% -$3.94K 0.08% 207
2013
Q2 		$2.34M Buy
+17,595
New +$2.48M 0.07% 216

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Nicholas Company's ELGX Position: Q2 2014 in Review

Nicholas Company sold out of Endologix Inc (ELGX) in Q2 2014, closing a stake of 17,670 shares — an estimated $2.27M sold.

Nicholas Company first reported a position in ELGX in Q2 2013 and held it in 4 quarters. The position peaked at $3.06M in Q4 2013. 119 funds tracked by Wall St. Rank hold ELGX as of Q2 2014.

  • Nicholas Company reported no remaining Endologix Inc position as of Q2 2014 after selling out during the quarter.
  • Nicholas Company sold 17,670 Endologix Inc shares in Q2 2014, an estimated $2.27M.
  • Nicholas Company first reported a position in Endologix Inc in Q2 2013 and held it in 4 quarters.
  • Nicholas Company's Endologix Inc position peaked at $3.06M in Q4 2013.
  • 119 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2014.

Based on Nicholas Company's 13F filing for Q2 2014, filed 14 Aug 2014.